In the absence of much federal action, states have enacted dozens of laws this year to lower prescription drug costs for their residents—and many more are considering following suit. The first ...

In the absence of much federal action, states have enacted dozens of laws this year to lower prescription drug costs for their residents—and many more are considering following suit. The first ...

Aalto University scientists have created a laser-based treatment that uses gentle heat to stop the progression of dry macular degeneration. The approach stimulates the eye’s natural cleanup and repair ...

Former President Joe Biden has completed a course of radiation therapy as he battles prostate cancer, a spokesperson for Biden told CNN. It is unclear what Biden’s next treatment steps might be. The ...

Former President Joe Biden is undergoing a new phase of treatment for an aggressive form of cancer that was diagnosed in May, a spokesperson said Saturday. "As part of a treatment plan for prostate ...

A new treatment that proves to slow the progression of Huntington’s disease (HD) marks a breakthrough for a condition that has long been considered untreatable. Huntington’s is a rare, inherited ...

Every week neurologist Victor Sung sees people with Huntington’s disease, a rare and deadly neurodegenerative disorder, at his clinic at the University of Alabama at Birmingham. But a Wednesday in ...

Bryce Vissel does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...

A gene therapy injected into patients’ brains slowed progression of the disease by 75 percent, preliminary findings reported. By Dana G. Smith Preliminary results from a small clinical trial to treat ...

With informed consent, you generally have the right to seek a second opinion or refuse treatment unless refusing poses a danger to the community or a court of law declares you “mentally incompetent.” ...

Real-world data suggest anti-TNF biosimilars for juvenile idiopathic arthritis offer comparable efficacy and safety to their brand name counterparts. As high-cost originator biologics continue to ...